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Abstract  
Virus entry  is  a multistep process that  triggers a variety  of  cellular  pathways 
interconnecting  into  a  complex  network,  yet  the  molecular  complexity  of  this 
network remains largely unsolved. Here, by employing systems biology approach 
to  combine  protein-interactions  from  existing  database  and  genome-wide 
transcriptome data, we reveal a systemic virus-entry network initiated by human 
cytomegalovirus  (HCMV),  a  widespread  opportunistic  pathogen.  This  network 
contains all known interactions and functional modules (i.e. groups of proteins) 
coordinately  responding  to HCMV  entry.  The  number  of  both  genes  and 
functional modules activated in this network dramatically declines shortly, within 
25  min  post-infection.  While  modules  annotated  as  receptor  system,  ion 
transport,  and  immune response  are  continuously  activated  during  the  entire 
process  of  HCMV entry,  those  for  cell  adhesion  and  skeletal  movement are 
specifically  activated  during  viral  early  attachment,  and  those  for  immune 
response during virus entry. HCMV entry requires a complex receptor network 
involving  different  cellular  components,  comprising  not  only  cell  surface 
receptors,  but  also  pathway  components  in  signal  transduction,  skeletal 
development,  immune  response,  endocytosis,  ion  transport,  macromolecule 
metabolism  and  chromatin  remodeling.  Interestingly,  genes  that  function  in 
chromatin remodeling are the most abundant in this receptor system, suggesting 
that global modulation of transcriptions is one of the most important events in 
HCMV entry. Results of in silico knock out further reveal that this entire receptor 
network is primarily controlled by multiple elements, such as EGFR (Epidermal 
Growth Factor) and SLC10A1 (sodium/bile acid cotransporter family, member 1). 
Thus,  our  results  demonstrate  that  a  complex  systemic  network,  in  which 
components coordinating efficiently in time and space contributes to virus entry. 
The findings and original network constructed here lay a foundation to further 
dissect the molecular complexity of virus entry and provide potential drug targets. 
Introduction
Virus  entry  activates  various  cellular  pathway  components.  For  decades, 
intensive studies on individual genes and pathways involved in virus entry have 
successfully provided us with  an unprecedented wealth of molecular detail  on 
how component proteins respond to virus entry [1]. Quite unexpectedly, however, 
drugs  targeting  individual  components  of  specialized  pathways  identified  in 
single-component  studies,  not  only  failed to  control  HCMV infection,  but  also 
caused huge unexpected side-effects[2].  Clearly,  virus entry is not simply the 
result of a single activated gene or pathway. Many proteins and pathways are 
continuously cross-talking to coordinate cellular signals during each step of virus 
entry, such as virus attachment, interaction with receptors, signaling, membrane 
fusion  and  endocytosis.  Nevertheless,  how  these  proteins  interact  with  each 
other to permit virus entry into cells is not completely understood. In particular,  
very  little  is  known  about  the  system-wide  network  and  functional  modules 
involved in virus entry, what the complete virus-receptor network looks like, and 
which proteins control  this  network.  This type of  knowledge is  the initial  step 
towards  completely  elucidating  the  complexity  of  virus  entry  and  developing 
efficient treatments to prevent virus spread to other cells.  
HCMV is a ubiquitous opportunistic pathogen that causes fatal or permanently 
debilitating disease in immunologically compromised individuals and neonates. 
Particularly at risk for infection with this virus are AIDS patients, cancer patients, 
organ  or  tissue  transplant  recipients  undergoing  immunosuppressive  therapy, 
infants,  fetuses,  and  the  elderly.   More  recently,  the  virus  has  also  been 
implicated  in  tumorigenesis[3],  and  the  etiology  of  circulatory  diseases,  most 
notably, atherosclerosis.  
HCMV entry into cells activates (up- and down-regulates) a variety of signaling 
pathways and multiple cellular receptors. HCMV attachment/entry (~ 5 to ~25 
min  post-infection  (PI)  triggers  components  and  pathways  linked  to  receptor 
tyrosine  kinase,  mitogen-activated  protein  kinase  signaling,  cytoskeletal 
rearrangement,  transcription  factors,  prostaglandins,  and  cytokines  [4].   In 
particular, HCMV entry activates epidermal growth factor receptor (EGFR), αvβ3 
integrin (α2ß1, α6ß1, and αvß3), and their signaling pathways [5-8], which play 
important roles in HCMV entry. Therefore, EGFR and αvβ3 integrin have been 
proposed as HCMV receptor and co-receptor, respectively [5-8]. However, EGFR 
is not expressed on all HCMV-permissive cell types that are efficiently infected by 
HCMV.  In  addition,  EGFR  might  not  be  essential  for  HCMV  entry[6],  and 
integrins only play a role in downstream events during HCMV entry[5-8]. In vivo, 
HCMV can infect almost every organ system and tissue type[4,6,9], and in vitro 
HCMV can promiscuously  penetrate diverse cell  lines with varying receptors. 
Together, these findings  suggest that HCMV entry activates multiple receptors 
that interact in a network, and that elucidating the HCMV entry process could 
provide valuable insights into the mechanism of virus entry in general.
     
It  can  be  extremely  challenging  for  traditional  genetics  and  biochemistry  to 
characterize a complex process like virus entry,  but  systems biology network 
approaches  (e.g.  system-wide  protein-protein  interaction  network)  can  greatly 
facilitate such a task[10]. Protein interactions can be physical binding interactions 
(e.g.  those  from  yeast  two-hybrid)  and  functional  interactions  (e.g.,  via 
interactions with phosphate groups on phosphoproteins). These interactions can 
be extracted from published databases and can be consolidated into genome-
wide comprehensive networks[11].  Systematic analysis of  these networks can 
simultaneously elucidate all possible pathway components associated with viral 
infection and the cross-talk that occur among these components in response to 
virus infection.  
In  this  study,  we  used  a  systems  biology  approach  for  the  first  time  to 
systematically  elucidate a comprehensive systemic network response to  virus 
attachment/entry, reveal a comprehensive virus receptor network, and identify in 
silico  the  essential  components  of  these  networks.  Our  work  provides  a
conceptual framework to further understand the fundamental molecular basis of 
virus entry. 
Results
A comprehensive protein-interaction network linked to HCMV entry
To systematically decode the systemic network activated by HCMV entry, we first 
utilized  systems  network  approaches  to  search  published  databases  for  all 
physical  and  functional  protein-protein  interactions  known  to  date  to  be 
associated  with  HCMV  attachment  and  entry  (see  Materials  and  Methods). 
These  interactions  were  then  combined  into  a  systemic  protein-interaction 
network database, which currently comprises 6651 nodes (proteins) and 64392 
edges  (interactions)  (Figure  1A,  Table  S1)  and  is  being  expanded  daily  as 
databases are updated.  
To examine the overall architectural features of this network, we analyzed overall  
node degree distribution, which represents the possibility of nodes having a given 
degree, and the number of incident edges to a given node. The node degree 
distribution of our network decreases with degree and approximates a power law 
(figure 1B), indicating that our network is a scale-free network, which is proposed 
as a universal network framework in biology networks[12-14].  In addition, we 
also calculated the average of the clustering coefficient C(k) distribution, which 
describes  how  nodes  link  to  others  via  their  K  neighbor  to  form  clusters  or 
groups. C(k) also diminishes with the increase in number of neighbors (figure 1B
), indicating that our network is a  hierarchical network [12-14] predominated by 
hubs (highly connected proteins) and bottlenecks, which are  nodes with many 
shortest  paths  going  through  them  analogous  to  key  bridges  that  link  sub-
networks to a whole map network [15].  Both hubs and bottlenecks likely play 
essential roles in this type of networks [12-15]. These distribution properties of 
our network are similar to other biological networks previously reported[12-14]. 
HCMV entry activates a complex systemic network
After constructing the comprehensive network database, we next enriched the 
network (figure 1) with genome-wide transcriptome data on genes significantly 
altered by HCMV attachment  and entry,  5  min and 25 min respectively  post 
infection of human primary foreskin fibroblasts, a common cell  line used as a 
model  of  HCMV infection. A total  of  408 and 240 genes showed significantly  
altered gene expression patterns at 5 min and 25 min PI respectively (Table S2-
S3). These enriched networks became systemic networks activated by HCMV 
attachment and entry (figure. 2). A total of 7 functional modules (figure 2) were 
activated at 5 min PI, including phosphorylation, intercellular junction assembly, 
iron transport, cell differentiation, vesicle-mediated transport, immune response, 
chromatin  disassembly,  macromolecule  metabolism,  cell  communication,  and 
signal transduction. At 25 min PI, 3 functional modules were activated, including 
immune  response,  transmembrane  receptor  protein  tyrosine  kinase  signaling 
pathway,  and  sodium  ion  transport.  This  rapid  decrease  in  the  number  of 
activated genes from 408 (5 min PI) to 240 (25 min PI) (Table S2-S3) within a 
very short time interval after HCMV infection, and the decline in network modules 
(from 7 to 3) fit the biphasic model of cellular response to infection [4], in which 
activation of cellular signaling peaks immediately in response to infection, then 
rapidly  declines  dramatically,  and  then  gradually  increases  again  to  another 
peak. 
While  modules  of  receptor  system,  ion  transport  and  immune  response 
dominated  the  entire  process  of  HCMV  entry,  cell  adhesion  and  skeletal 
movement were featured at 5 min PI and immune response predominated in the 
network at 25 min PI (figure 2). Notably, genes were not co-regulated in most of 
the modules activated during HCMV entry (figure 2), indicating that HCMV entry 
not only modulates different complex modules, but also mediates components 
within the same module. HCMV entry thereby elaborates module functions of the 
same module.
A systemic receptor network involved in HCMV entry 
Genes that are down-regulated could play an important role in HCMV attachment 
and entry, but the receptor system, in particular, should be up-regulated during 
these stages of  infection  [5-7].  Since the  network  comprising  down-regulated 
genes did not have any characterized functions (figure S1),  we focused on a 
systemic  receptor  network  containing  123  proteins  (Table  S4)  that  were 
enhanced  at  both  time  points  (5  min  and  25  min  PI).  This  network  was 
decomposed into 7 functional groups, including macromolecule metabolism and 
chromatin  remodeling,  signal  transduction,  cell  surface  receptor  pathway, 
skeletal development, immune response, endocytosis, and ion transport (figure 3
).  Consistent  with  previous  reports  about  HCMV  entry[4,5,9],  the  network 
includes  almost  all  known  pathways  and  their  components  up-regulated  by 
HCMV entry. Such pathways include receptor- like EGFR  in the receptor group, 
mitogen-activated protein kinase-like MAPK10 (mitogen-activated protein kinase 
10)  in  the signaling group,  components  for  cytoskeletal  rearrangement in  the 
skeletal group, transcription factors located in the nucleus, cytokines located in 
the extracellular space, and components for calcium transport in the ion transport 
group.  Importantly,  our  network  also  revealed a  systemic  view of  the  HCMV 
receptor system, in which genes are clustered into multiple functional groups of 
varied  pathways,  and  simultaneously  performing  various  functions  and 
bioprocesses during HCMV infection. For example, the receptor pathway group 
contains  18  different  receptor  components  (EGFR,  TP73L,  CCR5,  OR1A1, 
TCF4,  AVPR1B,  RELA,  GLP1R,  GNAO1,  SOST,  ADRA1A,  GNG4,  DGKA, 
PRB4,  NRP1,  DOK2,  SORCS2,  PTPRS),  the  skeletal  group  14  components 
(DLX2, BAPX1, SGCA, LMO2, HOXA2, IBSP, COL9A2, RUNX1, EGR1, ANKH, 
CSRP3,  ANXA13,  NPR3,  SOX6),  and the  ion  transport  group 8  components 
(SLC34A2, ATP7A, TRPM1, MBP, SLC10A1, VMD2, TRPC5, SLC17A2). While 
signal  transduction  for  cell  communication  and  cell  adhesion  dominated  the 
network, components for macromolecule metabolism and chromatin assembly or 
disassembly were surprisingly the most abundant in the network. This indicated 
that  chromatin  remodeling  is  one  of  the  major  bioprocesses  occurring  in  the 
human host  during HCMV attachment.   These data reveal  a  complex HCMV 
receptor  system  that  comprises  several  functional  sub-networks  that  are 
functionally  dominated  by  signal  transduction,  cell  adhesion,  and  chromatin 
remodeling.
Key proteins in the HCMV receptor network
To  identify  the  essential  components  in  the  HCMV  receptor  network,  we 
examined the contribution of individual components to the network by knocking 
out  single  genes  in  silico.  Special  attention  was  paid  to  protein  components 
located in the extracellular space and cell membrane (figure 3) because these 
components play crucial roles in initiating bioprocesses during HCMV entry, or 
serve  as  potential  HCMV receptors.  After  knocking  out  individual  genes,  we 
calculated the alterations in the average number of neighbors, which describes 
the  contribution  of  individual  nodes  to  network  connectivity,  and  the  mean 
shortest path, which measures the smallest number of links between selected 
nodes and essentially indicates network diameter. Node knockouts in a network 
would  decrease  network  connectivity.  Moreover,  knockout  of  nodes  that  are 
higher in the network hierarchy, would result in greater reduction of connectivity. 
As for diameter, the longer the diameter, the less interconnectivity there is in the 
network. Knocking out a hub would increase diameter because of the loss of 
short  paths in a network,  whereas knocking out a bottleneck would decrease 
diameter because the network would be broken down and the long path that 
normally link to sub-networks would be lost.
Results of in silico knock out experiments showed that the component EGFR 
contributed most in network connectivity and diameter (figure 4 A-B), indicating 
that  it  serves  as  a  hub  (highly  connected  proteins)  in  the  HCMV  receptor 
network.  Similarly,  IL4  (interleukin  4),  KRAS  (kirsten  rat  sarcoma  2  viral 
oncogene homolog), and IBSP (integrin-binding sialoprotein) also serve as hubs 
in this network activated by HCMV entry. In contrast, whereas CLU (clusterin) 
and SLC10A1 are also major contributors to network connectivity, knocking them 
out    resulted  in  a  decrease  in  network  diameter  (figure  4  B)  (figure  4A), 
indicating  that  these  two  components  serve  as  bottlenecks  in  this  network 
stimulated by HCMV attachment and entry. 
To confirm in silico the consequence of knocking out these hubs and bottlenecks, 
the structure of mutant and wild-type network activated by HCMV attachment and 
entry  was  compared  (figure  5).  While  knocking  out  hubs  like  EGFR  altered 
linkages of local sub-network (figure 5A and 5B), knocking out bottlenecks CLU 
and  SLC10A1  completely  broke  down  the  entire  network  into  at  least  two 
independent sub-networks as highlighted in figure 5C. These results indicate that 
both potential  hubs (EGFR, IL4, KRAS, and IBSP) and bottlenecks (CLU and 
SLC10A1) identified above are real hubs and bottlenecks in this network, and 
that they play important roles in this network. This finding is similar to reports  
about other networks in which hubs and bottlenecks are likely more essential in a 
network than other nodes [12-15].  
Discussion 
HCMV entry activates a complex systemic network
Studies on virus entry using traditional genetics and biochemistry approaches, 
have identified several viral entry pathways into host cells.  [1,5-7]. However, the 
molecular  mechanisms  underlying  virus  entry  remain  largely  elusive.  We 
systematically assembled the existing databases of all pathway components into 
a systemic scale-free network to elucidate the complexity of HCMV entry (figure 
1).  The  advantage  of  systems  network  approach  is  that  it  accounts  for  all 
interactions and cross-talks among components and treats the whole interactions 
as a network instead of linear circuits explicated by conventional approaches. 
The  cross-talk  that  has  been  mostly  ignored  in  conventional  studies  can 
significantly  contribute  to  real  phenotypes[16]  and  they  were  included  in  the 
present systemic network. The network constructed in the present study is based 
on current  database.  Future database updates and system-wide protein  data 
may slightly change the linkages in our network;  moreover,  our network data 
need  to  be  verified  by  direct  experimental  evidences  like  those  in  systems 
biology approaches. However, the overall architecture of our network database is 
not expected to change significantly because of its stable universal features, and 
scale-free  and  hierarchical structure  (Figure  1).  Therefore,  the  network 
constructed in this study can be adapted to analyze molecular mechanisms of 
host-microbe interactions in general, and can potentially find application in drug 
discovery against virus entry.
Entry of infectious agents into host cells activates complex bioprocesses [1,17-19
]. Previous studies demonstrated that HCMV entry stimulates gene expression of 
various  pathway  components,  such  as  those  involved  in  immune  response, 
calcium transport, and signal transduction [4-7,9,20,21]. In the present study, we 
systematically  identified  a  systemic  network  and  dynamic  molecular  modules 
activated  by  HCMV  entry,  which  includes,  not  only  genes  and  pathways 
previously reported, but also those uncovered in the present study (figure 2). 
Network module identification could be affected by network sources and some 
identified  modules  might  not  be  related  to  biological  functions[22].  However, 
since our network interactions were weighed on the basis of source confidences, 
and  then  network  topology  features  and  gene  functions  from  gene  ontology 
databases were combined to identify the network modules, our set of modules in 
this study likely represents a featured class of protein complexes in a natural 
biological network stimulated by HCMV entry. These functional modules can be 
used  to  further  model  the  quantitative  contribution  of  signal  transduction  of 
pathway components to HCMV entry by systems biology approaches. 
 The  dynamic  functional  modules  identified  here  were  activated  immediately 
upon infection. Modules of cell adhesion and skeletal movement were activated 
at ~5 min PI (figure 2), suggesting that HCMV enters the cell much earlier than 
thought. Notably, genes in most of the modules were not co-regulated (figure 2), 
suggesting  a  greater  molecular  complexity  of  HCMV  entry  than  previously 
thought. 
A complex receptor network involved
in HCMV entry
Infectious agents can easily bind to cell surfaces via chemical interactions, but 
with low affinity. Microbe-specific receptors and co-receptors are required to 
strengthen these bindings, but they are not likely sufficient for a successful 
entry, which require subtle contributions from other functional groups. For 
instance,  calcium transport  and cytoskeletal  movement,  which  are  often 
observed during microbe entry, are essential for surviving some receptor-
ligand  interactions  and  play  crucial  roles  in  strengthening  microbe-
attachment to cell surface [23]. Similar roles are true for signal transduction, 
immune response, and chromatin remodeling [23].  Therefore, a complex 
coordinated network is required for microbe entry into cells,  but has not 
been elucidated until now. [1,18,19,24]. Here, our data revealed a HCMV 
receptor  network  that  includes,  not  only  receptor  sub-network,  but  also 
chromatin remodeling, signal transduction, skeletal development, immune 
response,  endocytosis,  and  ion  transport  (figure  3).  Since  this  network 
contains all pathway components known to date to be related to virus entry, 
this network probably represents a complete coordinated network sufficient 
to  mediate  HCMV  entry.  Surprisingly,  genes  associated  with  chromatin 
remodeling  were  the  most  abundant  in  this  HCMV  receptor  network, 
suggesting that chromatin remodeling is a major event during HCMV entry. 
Bioprocesses  associated  with  microbe  entry  are  similar  for  different  microbe 
species, but the pathway components mediating these bioprocesses are usually 
species-specific. Particularly, cellular receptors are highly species-dependent. As 
for HCMV, integrin cellular co-receptors facilitate HCMV entry, but they only work 
in downstream receptor-ligand interactions during HCMV entry [5,8,9]. Indeed, a 
successful  integrin-ligand high affinity  attachment  depends on how molecules 
underneath  the  membrane  surface  respond  to  integrin-ligand  adhesion  [23]. 
Other proteins, such as  focal  adhesion kinase, phosphatidylinositol  phosphate 
kinase,  and  F-actin,  need  to  be  activated  before  integrin  receptor  activation 
[23,25]. Over-expression of genes in the receptor and signal transduction groups 
(figure  3)  might  account  for  the  integrin  activation.  For  example,  PIP5K3 
(phosphatidylinositol-3-phosphate/phosphatidylinositol 5-kinase, type I) regulates 
actin cytoskeleton and focal adhesion; Dok2 (docking protein 2) plays a crucial 
role in integrin outside-in signaling through a physical and functional interaction 
with integrin  αvβ3; MAPK10 (mitogen-activated protein kinase 10, MAP kinase 
activity)  plays  a key role  in  focal  adhesion;  RAP2A (RAS related protein  2a) 
engages  beta2  integrins;  IBSP  (integrin-binding  sialoprotein)  interacts  with 
integrins for cell adhesion. These findings further argue for integrins acting as 
downstream co-receptors for HCMV entry; meanwhile, the identity of the HCMV 
receptor remains elusive. 
Multiple receptors have been proposed for HCMV entry, but they have not been 
unambiguously identified [4-7,9]. Some of the 18 members of the receptor group 
in  figure  3 likely  act  as  HCMV receptors.    In  particular,  the  genes that  are 
essential  in  the  HCMV  receptor  network  might  be  much  more  important  for 
HCMV entry than receptors defined previously because of their essentiality in this 
network. Generally, hubs and bottlenecks are likely essential in a network [12-15
]. By knocking out genes in silico, we identified EGFR, IL4, KRAS, and IBSP as 
hubs;  and CLU and SLC10A1 as bottlenecks in  the  HCMV receptor  network 
(figure 4-5). Hubs and bottlenecks are new emerging concepts, and there is no 
available standard algorithm to identify them, so far. Identifications of hubs and 
bottleneck may be biased   depending on the algorithm and network resources 
used to construct the network.  We merged all databases in our study (figure 1)  
to  eliminate  database  bias,  and  the  node  contributions  for  both  network 
connectivity and diameter calculated here (figure 4-5) were consistent with those 
for  network  centrality[26]  that  are  essential  for  a  network  (data  not  shown). 
Therefore,  the hubs and bottlenecks identified here are likely essential  in the 
natural  HCMV-receptor  network  and constitute  the  group of  proteins  that  are 
likely essential for HCMV entry.          
As a member of hubs, EGFR was previously reported as an essential component 
of the HCMV receptor network although this result needs to be confirmed [6,7]. 
More detailed attention should be paid to the annotation of  egfr genes used in 
studies because, there are three annotated  egfr genes in the human genome; 
namely, accession number # AF277897 (located in chr7:55,200,539-55,203,821), 
#U95089  (chr7:55,054,067-55,192,136),  and  #U48722  (chr7:55,054,221-
55,192,136). Correspondingly, there are three probe-sets in the Affymetrix chip: 
1565484_x_at,  210984_x_at,  and  211607_x_at.  In  our  gene  expression 
experiments,  expression  of  the  egfr gene  corresponding  to  accession 
#AF277897  was  up-regulated,  but  the  other  two  egfr genes  were  down-
regulated.  We focused on the  EGFR with  accession  #AF277897 because its 
expression was enhanced at both time points (5 min and 25 min PI). Our network 
data also showed that the same EGFR plays an important, if not essential, role in 
HCMV attachment and entry, at least at the early stage (figure 4-5). A similar role 
was found for the other hubs. KRAS is a protein in the small GTPase superfamily 
that is activated by integrins during virus entry. KRAS also interacts with multiple 
immune receptors and is involved in multiple pathways related to cell adhesion 
and virus entry, such as regulation of actin cytoskeleton, tight junction, EGFR-
ErbB  (erythroblastoma  viral  gene  product  homolog)  signaling  pathway,  and 
mitogen-activated protein kinase (MAPK) signaling (http://www.genome.jp/kegg/). 
IL4 is a cytokine that facilitates virus entry[27]. IBSP is a sialoprotein that could 
bind to integrin as another component in the HCMV receptor system[5,8]. Two 
glycoproteins  (SLC10A1,  CLU)  were  identified  as  bottlenecks  (figure  4-5). 
SLC10A1 (solute  carrier  family  10)  belongs  to  sodium/bile  acid  cotransporter 
family. Ion transport plays an important role in integrin binding during virus entry 
as discussed above. In addition, SLC10A1 is also involved in lipid and lipoprotein 
metabolism  (http://www.reactome.org/cgi-bin/eventbrowser?
DB=gk_current&ID=73923), which might be related to the lipid rafts that signal 
during virus entry. CLU (clusterin) is one of the sulphated glycoproteins that is 
activated  by  virus  infection[28]  and  regulates  cell  communication  and  signal 
transduction  related  to  infection  like  the  lectin-induced  complement  pathway 
(http://www.invitrogen.com/content.cfm?pageid=10878),  and  the  NF-kappaB 
pathway[29].  Thus, these hubs and bottlenecks identified here are biologically 
important for HCMV entry.
In  this  study,  we used gene expression data to  enrich  the  protein-interaction 
network.  This  activated network may not  be completely consistent  with  those 
derived from protein level data, but genomics data measured by the Affymetrix 
microarray employed here are generally overlapping with the proteomics data [30
].  Our  findings about  the complex network activated by HCMV entry  and the 
HCMV receptor  network  should  emphasize  the  molecular  complexity  of  virus 
entry.  Targeting one or  two receptor  proteins as currently  employed may not 
efficiently  block  virus  entry  and  prevent  virus  spread  across  cells.  The  rapid 
change in dynamic modules makes it challenging to develop an efficient strategy 
to block virus entry, but the receptor network identified here and the approach we 
have  developed  should  lay  a  framework  to  further  dissect  the  molecular 
complexity of virus entry and facilitate efficient drug development. 
Methods and materials 
Network construction
Physical  interactions  were  extracted  from  protein-protein  binding  database 
(BIND,  DIP,  HPRD,  PreBIND, 
http://bond.unleashedinformatics.com/Action,  http://dip.doe-
mbi.ucla.edu/,  http://hprd.org/, 
http://www.blueprint.org/products/prebind/index.html,).  Functional 
interactions  were  derived  from  a  functional  experimental  database  and 
literature  mining,  including  curated inflammatory  disease database,  EMBL 
human  database  [11,31,32],  Cancer  Gene  Curation  database( 
http://ncicb.nci.nih.gov/NCICB/projects/cgdcp), and database for Agilent  
Literature  Search (  http://www.labs.agilent.com/sysbio/)  [31]  including 
PubMed(http://www.ncbi.nlm.nih.gov/entrez/query.fcgi),  OMIM 
(http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM),  and  USPTO 
(http://patft.uspto.gov). The network was visualized by Cytoscape [33] and 
is shown in Figure 1. The complete network is listed in table S1. 
Virus and Cells
HCMV  Towne  strain  (American  Type  Culture  Collection)  was  used  to  infect 
primary  human  foreskin  fibroblasts  (CC-2509)  at  a  MOI  of  10  as  previously 
described[34]. 
RNA extraction and microarray hybridization
Infected and uninfected cells were trypsinized and collected by centrifugation. 
RNA was purified using the RNeasy RNA purification kit  (QIAGEN Inc. 
Valencia, CA), followed by DNase treatment to eliminate all traces of DNA, 
according to the manufacturer's recommendation. GeneChip® One-Cycle 
Target Labeling and Control Reagents (Affymetrix, Santa Clara, CA) were 
used to process RNA and for hybridization following the manufacturer's 
protocols.  Affymetrix  Human  Genome  U133  Plus  2.0  Arrays,  which 
contains over 47,000 transcripts that completely cover the whole human 
genome, were employed in this study. 
Microarray data analysis
Algorithms  [35,36]  were  employed  to  analyze  microarray  data,  which  were 
normalized using the invariant set method [35,36]. The array with median CEL 
intensity  was  chosen  as  the  baseline  array.  The  model-base  (PM/MM) 
expression value was calculated. To minimize false positives, two steps were 
performed to filter the data. The first step compared samples (arrays) in a pair-
wise  fashion  with  the  threshold  for  fold  change at  >  2  with  90% confidence 
interval,  and a difference in expression values between the genes >100. The 
second filter criteria was set as coefficient of variation > 0.3, and the genes that 
were present were called at > 20%. Genes filtered from the screening criteria 
were taken to be the genes with significant alteration in gene expression, and 
used to enrich the network. 
Network analysis
Genes with significant alteration in gene expression at time points 0 min, 5 min, 
25 min PI were used to enrich the network initially constructed (figure 1 and 
table S1). Upon HCMV entry, the enriched network becomes an activated 
(up- and down regulated) network (Figures 2 and table S2). The network was 
analyzed  by  using  Network  Analyzer  (http://med.bioinf.mpi-
inf.mpg.de/netanalyzer/index.php).  The  activated  network  was  weighted 
on  the  basis  of  confidences  of  interaction  sources,  and  the  weighted 
networks  were decomposed into functional  modules based on topological 
interconnection intensity and gene functions (http://www.geneontology.org/) 
[37-40].  Genes  were  classified  according  to  gene  ontology  database 
(http://www.geneontology.org/) [39].
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Figure legends
Figure 1. A comprehensive regulatory network linked to HCMV entry. The 
network was constructed by using protein-protein binding database and protein 
functional database (see text and Materials and Methods for details). The insert 
shows a zoomed portion of entire network. The colors of nodes (proteins) and 
edges  (interactions)  represent  gene  expression  levels  and  edge  sources, 
respectively. The same color strategy for nodes and edges will be used for all  
figures in this study unless otherwise specified. Also shown are entire network 
properties, including node degree distribution that approximates a power law,P(k
)  ~ k  –  γ,  (γ  =  0.95  in  our  network),  and C(k)  distribution,  average clustering 
coefficient  that  measures  the  tendency  of  nodes  to  form  clusters[12],  which 
decreases with the number of neighbors.
Figure 2. Systemic networks and functional  modules activated by HCMV 
attachment and entry. The complete network activated by HCMV entry is listed 
in tables S2 and S3.  Only parts of entire networks are shown for clarity. 2A,  
functional modules activated at 5 min PI; 2B, activated network at 25 min PI. 
Figure 3. Network up-regulated by HCMV entry. Genes shown here were up-
regulated by HCMV entry at both 5 min and 25 min PI. Genes are clustered into 
functional groups and color-coded. Only the primary functions for each gene are 
indicated. Cellular components are shown on the left side.  
Figure  4.  Contribution  of  individual  genes  to  properties  of  the  network 
enhanced  by  HCMV entry. Extracellular  and  membrane  components  of  the 
network enhanced by HCMV entry (figure 3) were individually knocked out in 
silico, and the effects of such knock out were calculated.  Only genes with at  
least two direct neighbors in the network were knocked out because genes with 
only one direct neighbor or without neighbors are located at the end-terminal in 
the  network  and  would  not  significantly  affect  the  network  architecture.  4A, 
Contribution  of  individual  genes  to  network  connectivity.  4B,  Contribution  of 
individual genes to network diameter.  
Figure 5. Samples of in silico gene knock out in the network enhanced by 
HCMV entry. 5A, Entire wild-type network enhanced by HCMV entry with arrow 
pointing at genes to be knocked out.  Blue, potential  bottleneck nodes; green, 
potential  hubs.  5B,  Knocking  out  hubs  led  to  decrease  in  local  sub-network 
linkages as highlighted in green circle when compared to wild-type network. 5C, 
Knocking out bottleneck nodes broke down the entire network into at least two 
separated networks as highlighted in blue circles.  
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